(2E,6E)-hedycaryol

Details

Top
Internal ID a4cf7d19-07d3-4294-bb97-617626a4bfba
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Germacrane sesquiterpenoids
IUPAC Name 2-[(1R,3E,7E)-4,8-dimethylcyclodeca-3,7-dien-1-yl]propan-2-ol
SMILES (Canonical) CC1=CCCC(=CCC(CC1)C(C)(C)O)C
SMILES (Isomeric) C/C/1=C\CC/C(=C/C[C@@H](CC1)C(C)(C)O)/C
InChI InChI=1S/C15H26O/c1-12-6-5-7-13(2)9-11-14(10-8-12)15(3,4)16/h6,9,14,16H,5,7-8,10-11H2,1-4H3/b12-6+,13-9+/t14-/m1/s1
InChI Key SDMLCXJKAYFHQM-MKJLVJGCSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H26O
Molecular Weight 222.37 g/mol
Exact Mass 222.198365449 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 3.10
Atomic LogP (AlogP) 4.23
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
(+)-Hedycaryol
(1E,4E,7R)-germacra-1(10),4-dien-11-ol
2-[(1R,3E,7E)-4,8-dimethylcyclodeca-3,7-dien-1-yl]propan-2-ol
CHEBI:138043
C21698

2D Structure

Top
2D Structure of (2E,6E)-hedycaryol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9929 99.29%
Caco-2 + 0.9207 92.07%
Blood Brain Barrier + 0.8500 85.00%
Human oral bioavailability + 0.6571 65.71%
Subcellular localzation Lysosomes 0.4421 44.21%
OATP2B1 inhibitior - 0.8464 84.64%
OATP1B1 inhibitior + 0.9715 97.15%
OATP1B3 inhibitior + 0.9239 92.39%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior - 0.7770 77.70%
P-glycoprotein inhibitior - 0.9393 93.93%
P-glycoprotein substrate - 0.9262 92.62%
CYP3A4 substrate - 0.5876 58.76%
CYP2C9 substrate - 0.5790 57.90%
CYP2D6 substrate - 0.7630 76.30%
CYP3A4 inhibition - 0.8499 84.99%
CYP2C9 inhibition - 0.5563 55.63%
CYP2C19 inhibition - 0.6210 62.10%
CYP2D6 inhibition - 0.9308 93.08%
CYP1A2 inhibition - 0.7261 72.61%
CYP2C8 inhibition - 0.7092 70.92%
CYP inhibitory promiscuity - 0.7255 72.55%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.7528 75.28%
Carcinogenicity (trinary) Non-required 0.5749 57.49%
Eye corrosion - 0.8491 84.91%
Eye irritation + 0.6179 61.79%
Skin irritation + 0.7414 74.14%
Skin corrosion - 0.9655 96.55%
Ames mutagenesis - 0.9500 95.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6709 67.09%
Micronuclear - 0.9900 99.00%
Hepatotoxicity + 0.5178 51.78%
skin sensitisation + 0.8579 85.79%
Respiratory toxicity - 0.8333 83.33%
Reproductive toxicity - 0.8444 84.44%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity - 0.6819 68.19%
Acute Oral Toxicity (c) IV 0.4987 49.87%
Estrogen receptor binding - 0.8513 85.13%
Androgen receptor binding - 0.8635 86.35%
Thyroid receptor binding - 0.6073 60.73%
Glucocorticoid receptor binding - 0.7405 74.05%
Aromatase binding - 0.8197 81.97%
PPAR gamma - 0.7444 74.44%
Honey bee toxicity - 0.9536 95.36%
Biodegradation + 0.6000 60.00%
Crustacea aquatic toxicity - 0.5100 51.00%
Fish aquatic toxicity + 0.9759 97.59%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.96% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.01% 91.11%
CHEMBL2581 P07339 Cathepsin D 88.17% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.01% 95.56%
CHEMBL3192 Q9BY41 Histone deacetylase 8 84.27% 93.99%
CHEMBL1871 P10275 Androgen Receptor 83.34% 96.43%
CHEMBL3137262 O60341 LSD1/CoREST complex 83.28% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.82% 100.00%
CHEMBL3359 P21462 Formyl peptide receptor 1 81.44% 93.56%
CHEMBL3401 O75469 Pregnane X receptor 80.49% 94.73%

Cross-Links

Top
PubChem 10998630
NPASS NPC81500
LOTUS LTS0202707
wikiData Q74417322